OM SEC Filings: 8-K, 10-Q, S-3 & 424B – Outset Medical

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 4, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 6, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 7, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Feb 13, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 10, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 6, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Outset Medical Reports Third Quarter 2026 Results

Nov 4, 2026

8-K

Outset Medical Announces Departure of General Counsel John Brottem

Aug 28, 2026

8-K

Outset Medical Reports Second Quarter 2026 Financial Results and New HCA Healthcare Agreement

Aug 6, 2026

8-K

Outset Medical Enters $40 Million Fleet Refresh Agreement with HCA

Jun 17, 2026

8-K

Outset Medical, Inc. Announces Results of 2026 Annual Meeting of Stockholders

Jun 5, 2026

8-K

Departure of Outset Medical Executive Vice President Marc Nash

May 29, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B3

Form 424B3 - Prospectus [Rule 424(b)(3)]

Feb 28, 2025

424B4

5,944,859 Shares-

Apr 9, 2021

424B4

4,000,000 Shares-

Dec 3, 2020

424B4

8,951,111 Shares

Sep 16, 2020

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Feb 13, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jun 5, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Feb 28, 2025

S-3/A

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

Feb 26, 2025

S-3

Form S-3 - Registration statement under Securities Act of 1933

Feb 13, 2025

Form D - Notice of Exempt Offering of Securities - Item 06b

Jan 17, 2025

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 24, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 24, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

May 14, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 11, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 11, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Feb 4, 2025

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G/A

BML Investment Partners, L.P. (Filed by)

Oct 6, 2026

Leonard Braden Michael (Reporting)

Oct 5, 2026

Trigg Leslie (Reporting)

Aug 18, 2026

Brottem John L. (Reporting)

Aug 18, 2026

Gaeta Renee (Reporting)

Aug 18, 2026

144

Form 144 - Report of proposed sale of securities

Aug 14, 2026

Other

TYPE

HEADLINE

FILED AT

Outset Medical, Inc. OM · SEC Filings